Thursday, March 26, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > Constellation CEO attributes beer sales decline to immigration crackdown

Constellation CEO attributes beer sales decline to immigration crackdown

in News
Constellation CEO attributes beer sales decline to immigration crackdown
Share on LinkedinShare on WhatsApp

Constellation Brands has released its Q1 2025 earnings report, revealing a decline in beer sales, which the company’s CEO attributes to the recent immigration crackdown in the U.S.

The brand reported that it “continued to face softer consumer demand” in Q1, “driven by what we believe to be non-structural socioeconomic factors.”

Contellation beer sales fell 2% during the quarter, while the company stated that, “Over 80% of the surveyed Hispanic and non-Hispanic consumers expressed concerns about the socioeconomic environment in the U.S. and more than 70% are specifically concerned about their personal finances.”

“These concerns are impacting social occasions and shopping behaviors with respondents placing gatherings with friends and family in public spaces, gatherings with friends and family at homes, and shopping in convenience stores or gas stations in the top three activities they are doing less of in the last 3 months.”

Constellation Brands, owners of Modelo, Corona, and Pacifico, state that about half of their beer sales are generated by the Latino population of the U.S.

During an earnings call, Constellation CEO Bill Newlands acknowledged that raids by U.S. Immigration and Customs Enforcement were complicating the ability to predict consumer behavior. “When you see a fair amount of change, both Hispanic and non-Hispanic consumers are concerned about inflation and about cost structure.”

In a joint statement the company’s CFO, Garth Hankinson and CEO, Bill Newlands said; “For fiscal 2026, we expect organic Enterprise net sales to be down approximately 2% to up approximately 1%.”

Moving forward, “While our fiscal 2026 outlook remains unchanged, we continue to closely monitor whether recent revisions to key macroeconomic forecasts will result in additional consumer demand softness – and as always, we will consider all potential actions available to address any incremental headwinds while also evaluating how these factors may ultimately impact our current expectations.”

By CEO NA Editorial Staff

Related Posts

Henkel to acquire Olaplex in $1.4 billion deal
News

Henkel to acquire Olaplex in $1.4 billion deal

Five key takeaways from earnings season
News

U.S. inflation set to hit 4.2% this year

Equitable and Corebridge announce merger
News

Equitable and Corebridge announce merger

Retailers Earnings Reinforce Inflation Fears
News

US import prices post largest gain since 2022

Merck buys Terns Pharmaceuticals for $6.7 billion
News

Merck buys Terns Pharmaceuticals for $6.7 billion

AMD and Meta announce expanded strategic partnership 
News

Meta to pay $375 million in New Mexico case

Bank of Montreal launches tokenized cash platform with CME and Google
News

Bank of Montreal launches tokenized cash platform with CME and Google

Amid tariff setbacks, Gap CEO says turnaround strategy is working
News

Gap launches AI-Powered fit and conversational checkout on Google Gemini

Chevron CEO says traders have ‘scant information’ on oil market
News

Chevron CEO says traders have ‘scant information’ on oil market

Kali Therapeutics signs $180 million deal with Sanofi to develop autoimmune treatments
News

Kali Therapeutics signs $180 million deal with Sanofi to develop autoimmune treatments

No Result
View All Result

Recent Posts

  • Corporate reputation is a key motivator for consumers to pay more
  • White House to pay TotalEnergies $1 billion to kill off East Coast wind farm projects
  • Henkel to acquire Olaplex in $1.4 billion deal
  • U.S. inflation set to hit 4.2% this year
  • Equitable and Corebridge announce merger

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

Avenida Chapultepec 480,
Floor 11
Mexico City
06700
MEXICO

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.